-+ 0.00%
-+ 0.00%
-+ 0.00%

NOVAVAX EARNS $125 MILLION MILESTONE AS SANOFI LAUNCHES PHASE 3 INFLUENZA-COVID-19 COMBINATION VACCINE TRIAL IN EUROPE

Reuters·10/29/2026 13:39:02